first-line therapy

January 9, 2019January 31, 2019

First-line Imbruvica-Gazyva Therapy Extends Survival Without Disease Progression in CLL/SLL Patients, Phase 3 Study Shows

News

First-line treatment with Imbruvica (ibrutinib) plus Gazyva (obinutuzumab) significantly extends the time patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) live without cancer progression, and it also increases their ... Read more

April 20, 2018

Patients with Peripheral T-cell Lymphoma Resistant to First-Line Therapy Show Worse Outcomes, Study Finds

News

Patients with peripheral T-cell lymphomas receiving standard treatment have worse outcomes if they are not responsive to first-line therapy, a prospective study shows. Bone marrow transplants undertaken after these therapies have ... Read more

January 19, 2017

No Tumors at 30 Months May Be Good Marker in Follicular Lymphoma Therapy Assessments, Study Says

News

No tumors at 30 months may be a good marker of progression-free survival (PFS) in clinical trials assessing first-line therapies for follicular lymphoma patients, according to new research. Using a tumor-free ... Read more